…my new PAINWeekEnd talks on risk mitigation and documentation are designed to help you demonstrate meaningful risk mitigation processes and document individualized patient care plans. The time you invest…will help preserve patient access to quality pain care!
MONTCLAIR, N.J. (PRWEB)
February 20, 2020
PAINWeekEnd on March 21 and 22 at the Hilton Scottsdale Resort, 6333 North Scottsdale Road, in Arizona, will be a timely and relevant 2-day program providing busy clinicians and allied healthcare practitioners with 12.0 hours of relevant, practical instruction in the management of chronic pain.
In 2020, paper prescriptions for certain painkillers have been banned in Arizona. For schedule II controlled opioids, healthcare professionals are required to submit prescriptions electronically to pharmacists, to crack down on forged prescriptions. This requirement is part of the Arizona Opioid Epidemic Act signed into law by Governor Doug Ducey in 2018.
At PAINWeekEnd Scottsdale, senior faculty member Jen Bolen will be among the presenters. Her presentations are called: Drugs, Documentation, and DEA: Improving your Charting of Prescribing Rationale in 2020 and Beyond and Through the Lens of Experts: Meaningful Risk Mitigation and Patient Education. Attorney Bolen commented, “The DEA and licensing boards continue to aggressively pursue cases against healthcare providers for inappropriate opioid prescribing. Bad outcomes in these cases are typically the result of overly generalized risk mitigation processes and poor documentation. While you may not be able to stop an investigation or lawsuit, my new PAINWeekEnd 2020 talks on risk mitigation and documentation are designed to help you demonstrate meaningful risk mitigation processes and document individualized patient care plans. The time you invest in yourself and your practice skills will be well spent, and will help preserve patient access to quality pain care! See you soon!”
Other courses include Pain Pathways Made Simple; Nonopioid Analgesics, Adjuvants, and Antidepressants; Interventional Pain Management: Opioid-Sparing Technologies; Clinical Pearls: Unraveling the Secrets of Imaging Studies; Rational Polypharmacy; Spinal Stenosis: Epidemiology, Pathophysiology, and Treatment; After the Goldrush: Testing Medical Cannabis and CBD in Chronic Pain Patients; What’s All the “GABA” About? Pregabalin and Gabapentin Abuse; and Everybody’s Greasing Up, But Should You Rub It In? A Review of Topical Analgesics and Available Evidence in Clinical Trials.
Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.
For more information about this or other regional conferences, and to register for $199, go to the PAINWeekEnd website. BONUS: PAINWeekEnd registrants may register for the 2020 PAINWeek National Conference, September 8-12, in Las Vegas, for $200 off the regular online published price.
Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.
Share article on social media or email: